|
4FYQ
Human aminopeptidase N (CD13)
Deposited 2012-07-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
66–967(902 aa)
Fragment:UNP residues 66-967
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12
ZN ZINC ION × 2
SO4 SULFATE ION × 22
ACY ACETIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
hanging drop vapor diffusion;pH 5;295 K;2M ammonium sulfate, 0.1M sodium acetate, 10% glycerol, pH 5.0, hanging drop vapor diffusion, temperature 295K
|
Resolution 1.90 Å
R-free 0.193
|
|
4FYR
Human aminopeptidase N (CD13) in complex with bestatin
Deposited 2012-07-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
66–967(902 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 14
ZN ZINC ION × 2
BES 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID × 2
SO4 SULFATE ION × 20
ACY ACETIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
hanging drop vapor diffusion;pH 5;295 K;2M ammonium sulfate, 0.1M sodium acetate, 10% glycerol, pH 5.0, hanging drop vapor diffusion, temperature 295K
|
Resolution 1.91 Å
R-free 0.190
|
|
4FYS
Human aminopeptidase N (CD13) in complex with angiotensin IV
Deposited 2012-07-05
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
66–967(902 aa)
Fragment:UNP residues 66-967
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
SO4 SULFATE ION × 11
|
X-RAY DIFFRACTION
X-ray crystallization conditions
hanging drop vapor diffusion;pH 5;295 K;2M ammonium sulfate, 0.1M sodium acetate, 10% glycerol, pH 5.0, hanging drop vapor diffusion, temperature 295K
|
Resolution 2.01 Å
R-free 0.198
|
|
4FYT
Human aminopeptidase N (CD13) in complex with amastatin
Deposited 2012-07-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
66–967(902 aa)
Fragment:UNP residues 66-967
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 10
ZN ZINC ION × 2
SO4 SULFATE ION × 24
|
X-RAY DIFFRACTION
X-ray crystallization conditions
hanging drop vapor diffusion;pH 5;295 K;2M ammonium sulfate, 0.1M sodium acetate, 10% glycerol, pH 5.0, hanging drop vapor diffusion, temperature 295K
|
Resolution 1.85 Å
R-free 0.183
|
|
5LHD
Structure of glycosylated human aminopeptidase N
Deposited 2016-07-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
36–967(932 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
ZN ZINC ION × 1
EDO 1,2-ETHANEDIOL × 17
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;50 mM Imidazol-HCl pH 8.0, 20% PEG6000
|
Resolution 2.60 Å
R-free 0.214
|
|
5LHD
Structure of glycosylated human aminopeptidase N
Deposited 2016-07-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
36–967(932 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
ZN ZINC ION × 1
EDO 1,2-ETHANEDIOL × 12
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;50 mM Imidazol-HCl pH 8.0, 20% PEG6000
|
Resolution 2.60 Å
R-free 0.214
|
|
5LHD
Structure of glycosylated human aminopeptidase N
Deposited 2016-07-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
36–967(932 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
ZN ZINC ION × 1
EDO 1,2-ETHANEDIOL × 12
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;50 mM Imidazol-HCl pH 8.0, 20% PEG6000
|
Resolution 2.60 Å
R-free 0.214
|
|
5LHD
Structure of glycosylated human aminopeptidase N
Deposited 2016-07-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
36–967(932 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
ZN ZINC ION × 1
EDO 1,2-ETHANEDIOL × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;50 mM Imidazol-HCl pH 8.0, 20% PEG6000
|
Resolution 2.60 Å
R-free 0.214
|
|
6ATK
Crystal structure of the human coronavirus 229E spike protein receptor binding domain in complex with human aminopeptidase N
Deposited 2017-08-29
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
66–967(902 aa)
Fragment:UNP residues 68-967
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;8% PEG 8000, 1mM GSSG, 1mM GSH, 5% Glycerol, 100mM MES, 1ug/mL endo-beta-N-acetylglucosaminidase A
|
Resolution 3.50 Å
R-free 0.267
|
|
6ATK
Crystal structure of the human coronavirus 229E spike protein receptor binding domain in complex with human aminopeptidase N
Deposited 2017-08-29
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
66–967(902 aa)
Fragment:UNP residues 68-967
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;8% PEG 8000, 1mM GSSG, 1mM GSH, 5% Glycerol, 100mM MES, 1ug/mL endo-beta-N-acetylglucosaminidase A
|
Resolution 3.50 Å
R-free 0.267
|
|
6ATK
Crystal structure of the human coronavirus 229E spike protein receptor binding domain in complex with human aminopeptidase N
Deposited 2017-08-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
66–967(902 aa)
Fragment:UNP residues 68-967
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;8% PEG 8000, 1mM GSSG, 1mM GSH, 5% Glycerol, 100mM MES, 1ug/mL endo-beta-N-acetylglucosaminidase A
|
Resolution 3.50 Å
R-free 0.267
|
|
6U7E
HCoV-229E RBD Class III in complex with human APN
Deposited 2019-09-02
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
66–967(902 aa)
Fragment:ectodomain (UNP residues 66-967)
|
Not recorded
|
ZN ZINC ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;9% PEG8000, 1 mM oxidized glutathione, 1 mM reduced glutathione, 5% glycerol, 100 mM MES, pH 6.5
|
Resolution 3.00 Å
R-free 0.244
|
|
6U7E
HCoV-229E RBD Class III in complex with human APN
Deposited 2019-09-02
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
66–967(902 aa)
Fragment:ectodomain (UNP residues 66-967)
|
Not recorded
|
ZN ZINC ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;9% PEG8000, 1 mM oxidized glutathione, 1 mM reduced glutathione, 5% glycerol, 100 mM MES, pH 6.5
|
Resolution 3.00 Å
R-free 0.244
|
|
6U7F
HCoV-229E RBD Class IV in complex with human APN
Deposited 2019-09-02
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
66–967(902 aa)
Fragment:ectodomain (UNP residues 66-967)
|
Not recorded
|
ZN ZINC ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;9% PEG8000, 1 mM oxidized glutathione, 1 mM reduced glutathione, 5% glycerol, 100 mM MES, pH 6.5
|
Resolution 2.75 Å
R-free 0.225
|
|
6U7F
HCoV-229E RBD Class IV in complex with human APN
Deposited 2019-09-02
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
66–967(902 aa)
Fragment:ectodomain (UNP residues 66-967)
|
Not recorded
|
ZN ZINC ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;9% PEG8000, 1 mM oxidized glutathione, 1 mM reduced glutathione, 5% glycerol, 100 mM MES, pH 6.5
|
Resolution 2.75 Å
R-free 0.225
|
|
6U7G
HCoV-229E RBD Class V in complex with human APN
Deposited 2019-09-02
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
66–967(902 aa)
Fragment:ectodomain (UNP residues 66-967)
|
Not recorded
|
ZN ZINC ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;9% PEG8000, 1 mM oxidized glutathione, 1 mM reduced glutathione, 5% glycerol, 100 mM MES, pH 6.5
|
Resolution 2.35 Å
R-free 0.218
|
|
6U7G
HCoV-229E RBD Class V in complex with human APN
Deposited 2019-09-02
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
66–967(902 aa)
Fragment:ectodomain (UNP residues 66-967)
|
Not recorded
|
ZN ZINC ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;9% PEG8000, 1 mM oxidized glutathione, 1 mM reduced glutathione, 5% glycerol, 100 mM MES, pH 6.5
|
Resolution 2.35 Å
R-free 0.218
|
|
7AEW
14-3-3 sigma bound to bis-phosphorylated aminopeptidase N (APN, CD13) via canonical and non-canonical binding motifs
Deposited 2020-09-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain BBB
36–73(38 aa)
Chain CCC
36–73(38 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NA SODIUM ION × 8
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M HEPES pH 7.7
0.19 M CaCl2
5% glycerol
27 % PEG400
|
Resolution 1.20 Å
R-free 0.184
|
|
8WDE
CryoEM structure of the spike protein of human CoV 229E in complex with receptor hAPN (composite map)
Deposited 2023-09-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain D
66–967(902 aa)
Chain E
66–967(902 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 20
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.6
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å
|
|
9CAM
Aminopeptidase N close state
Deposited 2024-06-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–967(967 aa)
Chain B
1–967(967 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
ZN ZINC ION × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.96 Å
|
|
9CAO
Aminopeptidase N open state
Deposited 2024-06-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–967(967 aa)
Chain B
1–967(967 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
ZN ZINC ION × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.14 Å
|